نتایج جستجو برای: hematopoietic stem cell

تعداد نتایج: 1815814  

Journal: :international journal of hematology-oncology and stem cell research 0
seyed asadollah mousavi hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran vahid moazed hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran niayesh mohebbi research center for rational use of drugs and department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran molouk hadjibabaie faculty of pharmacy, and research center for rational use of drugs, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran babak bahar hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran

abstract background hemorrhagic cystitis(hc)is one of the most challenging complications in hematopoietic stem cell transplantation(hsct). estrogen is one of the suggested treatments for controllingthis problem. material and methods we performed a randomizedcase - controlled study to evaluate the efficacy of oral conjugated estrogen on hc management in 56hsct patients.patients were randomly ass...

Journal: :journal of pharmaceutical care 0
molouk hadjibabaie research center for rational use of drugs, tehran university of medical sciences, tehran, iran and department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. soroush alborz department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. mannan hajimahmoudi department of drug and food control, faculty of pharmacy, tehran university of medical sciences, tehran, iran. ava mansouri research center for rational use of drugs, tehran university of medical sciences, tehran, iran. amirali hamidieh hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran. mania radfar department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran.

background: thalassemic patients undergoing hematopoietic stem cell transplantation (hsct) are faced with cumulative high level of oxidative stress and depletion of critical antioxidants. administration of antioxidants, is promising towards minimizing oxidative damage in both thalassemic and hsct patients. method: this was a prospective cross-sectional observational study. patients as a part of...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: the traditional goal of the treatment of acute myelogenous leukemia is to produce and maintain a complete remission (cr).the difference in survival time was entirely attributable to the duration of time spent in cr .in this study, the outcome of aml patients with allogeneic hsct in cr1 versus other than cr1 was compared. patients and methods: since march 1991 until november 2008, ...

Journal: :international journal of hematology-oncology and stem cell research 0
c kani hematology, oncology and bone marrow transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran a mousavi hematology, oncology and bone marrow transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran m iravani hematology, oncology and bone marrow transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran k alimoghaddam hematology, oncology and bone marrow transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran b bahar hematology, oncology and bone marrow transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran m jahani hematology, oncology and bone marrow transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran

objective: to evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic hsct recipients.patients and method: in this single-center study, 111 consecutive febrile episodes in 104 neutropenic hsct recipients with a mean age of 26 years were randomized to treatment either with imipenem/cilastatin 1 g, iv, q8h or cefepime (our standard regimen) 2 g, iv, q8h. if fe...

Amirpoya Tanhaee Leila Dehghani Rokhsareh Meamar Shahrzad Nematollahi

The complexity of multiple sclerosis (MS) and the incompetence of a large number of promise treatments in MS urge us to plan new and more effective therapeutic approaches that aim to suppress ongoing autoimmune responses and induction of local endogenous regeneration. Emerging data propose that hematopoietic, mesenchymal and neural stem cells have the potential to restore self-tolerance, to pro...

Nikougoftar Zarif M,

Cord blood hematopoietic stem cells are widely used as an alternative source for hematopoietic stem cells transplant. Increasing rate of patients who need hematopoietic stem cells transplant and many advantages of cord blood in comparison to bone marrow hematopoietic stem cells, have promoted banking of cord blood units. Cord blood banking requires accurate steps in donor selection, cord blood ...

Abbas Hajifathali, AliAkbar Pourfathollah, Hossein Mozdarani, Kamran Alimoghaddam, Mahin Nikogoftar, Masoud Soleimani, Yousef Mortazavi, Zahra Zonobi,

Many investigators have used xenogeneic, especially murine stromal cells and fetal calf serum to maintain and expand human stem cells. The proliferation and expansion of human hematopoietic stem cells in ex vivo culture were examined with the goal of generating a suitable protocol for expanding hematopoietic stem cells for patient transplantation. Using primary fetal liver cells, we established...

آتشی, امیر, زمانی, هما, پرهیزکار, فاطمه, کاویانی جبلی, سعید,

Background and Objective: Mobilization of Hematopoietic Stem Cells (HSCs) for transplantation and the importance of -adrenergic signals in induction of this process have been well investigated. However, little is known about the role of -adrenergic signals in mobilization of HSCs and factors influenced by these signals. The Chemokine Stromal Derived Factor -1 (SDF-1) which is expressed by hum...

Journal: :international journal of hematology-oncology and stem cell research 0
kamran alimoghaddam hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran mohamad jahani hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran arash jalali hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran hoda jorjani hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran massoud iravani hematology oncology and stem cell transplantation research center of tehran university of medical sciences, tehran, iran

introduction: acute promyelocytic leukemia treatment revolutionized by new tretamnets. currently number of patinets who undergoe hematopoietic stem cell transplantation decrased so experience with this modality is limited. here we report our experience with stem cell transplantation in acute promyelocytic leukemia patients. design and setting: retrospective, single center methods: between year ...

ژورنال: دانشور پزشکی 2016
آرام‌وش, آسیه, ربّانی‌چادگانی, ,

Stem cells occur in many somatic tissues of multicellular organism and are important participants in their physiology. Stem cells have three distinctive properties: 1- self-renewal, 2- the potential to proliferate extensively and 3- capability to develop into multiple lineages. Every time a stem cell divides, it makes one exact copy and one progenitor cell. Progenitor cells have finite division...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید